Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies

Background: SARS-CoV-2 vaccination is crucial for protecting against severe COVID-19 disease; however, patients with haematological malignancies (HM) respond poorly to vaccination due to immunosuppression driven by chemotherapy, targeted cell depletion, and immune dysregulation. We sought to define...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sophie C. Hamann, Katie E. Lineburg, Louise Ng, Annabel Waugh, Stuart Olver, Justine Leach, Christine Bristow, Jyothy Raju, Laetitia Le Texier, Pauline Crooks, Corey Smith, Kristyan Guppy-Coles, Kirk Morris, Michelle Spanevello, Siok-Keen Tey, Andrea S. Henden
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-02-01
סדרה:	Vaccines
נושאים:	SARS-CoV-2 vaccination haematological malignancy immune responses
גישה מקוונת:	https://www.mdpi.com/2076-393X/14/3/201
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!